Identification of Mutation Landscape and Immune Cell Component for Liver Hepatocellular Carcinoma Highlights Potential Therapeutic Targets and Prognostic Markers

Liver hepatocellular carcinoma (LIHC) is a primary malignancy, and there is a lack of effective treatment for advanced patients. Although numerous studies exist to reveal the carcinogenic mechanism of LIHC, few studies have integrated multi-omics data to systematically analyze pathogenesis and revea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hengzhen, Jiang, Wenjing, Wang, Haijun, Wei, Zheng, Li, Hali, Yan, Haichao, Han, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481807/
https://www.ncbi.nlm.nih.gov/pubmed/34603396
http://dx.doi.org/10.3389/fgene.2021.737965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481807/
https://www.ncbi.nlm.nih.gov/pubmed/34603396
http://dx.doi.org/10.3389/fgene.2021.737965

Ejemplares similares